Related Experiment Video
Updated: Aug 8, 2026
16:01
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
The mast cell and mast cell disease
1Yale University School of Medicine, Department of Dermatology, New Haven, CT 06520-8059.
Journal of the American Academy of Dermatology
|April 1, 1995
Summary
Mast cell disease, or mastocytosis, involves abnormal mast cell growth, primarily in the skin but potentially affecting multiple organ systems. Effective management requires understanding mast cell mediator effects and release triggers.
Area of Science:
- Hematology
- Dermatology
- Immunology
Background:
- Mast cell disease, also known as mastocytosis, is a group of disorders.
- It is characterized by the abnormal proliferation and accumulation of mast cells.
- These cells can infiltrate various tissues, most commonly the skin.
Purpose of the Study:
- To provide a comprehensive overview of mast cell disease (mastocytosis).
- To highlight the diverse clinical manifestations based on mast cell localization.
- To emphasize the importance of understanding mast cell mediators for effective management.
Main Methods:
- Review of existing literature on mastocytosis.
- Analysis of clinical presentations and pathological findings.
- Synthesis of information on mast cell mediator effects and management strategies.
Main Results:
- Mastocytosis presents heterogeneously, with skin being the most frequent site of involvement.
- Symptoms vary widely depending on the affected organs (skin, skeletal, hematopoietic, gastrointestinal, cardiopulmonary, CNS).
- Mediators released by mast cells cause local and systemic effects.
Conclusions:
- Clinical management of mastocytosis hinges on understanding mast cell mediator actions.
- Knowledge of stimuli triggering mast cell degranulation is crucial.
- Awareness of therapeutic strategies to block mediator effects is essential for patient care.
Related Concept Videos
01:38Inflammation
Overview
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...